Company intelligence / Profile preview

VIDAL Group

Paris, Île-de-France, France

Ownership: Private
Employees: ~400
Development stage: Other

Overview

VIDAL Group operates the leading drug information platform in France and Europe, integrated into over 400 medical software systems and serving over 700,000 healthcare professionals in 30 countries. Their drug databases are considered the gold standard reference for prescription safety and therapeutic decision support.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Datapharm (UK): Partnership to integrate SRD Search tech for medicines information in FranceMILE (Medical Information Leaders in Europe): Collaboration on scientific response documents

Beyond the preview

Go deeper on VIDAL Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIDAL Group.

Explore the full profile